C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups

Patents for C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups (57,272)
03/2011
03/24/2011	US20110071202 Anti-hepatitis c virus agents and anti-hiv agents
03/24/2011	US20110071189 3-substituted-2(arylalkyl)-1-azabicycloalkanes and methods of use thereof
03/24/2011	US20110071188 3-substituted-2(arylalkyl)-1-azabicycloalkanes and methods of use thereof
03/24/2011	US20110071187 3-substituted-2(arylalkyl)-1-azabicycloalkanes and methods of use thereof
03/24/2011	US20110071180 Sub-type selective amides of diazabicycloalkanes
03/24/2011	US20110071179 Macrocyclic inhibitors of jak
03/24/2011	US20110071172 Substituted quinazolines as blood platelet lowering agents
03/24/2011	US20110071171 2h- pyrimido [2, 1-b] quinazolin-2-one derivatives and their use as platelet anti-aggregative agents
03/24/2011	US20110071143 Fused triazole amines as p2x7 modulators
03/24/2011	US20110071136 Novel tricyclic protein kinase modulators
03/24/2011	US20110071129 Spirodiamine-diaryl ketoxime derivative
03/24/2011	US20110071128 Novel imidazopyridines
03/24/2011	US20110071115 Pharmaceutically useful heterocycle-substituted lactams
03/24/2011	US20110070305 Sustained release pharmaceutical composition containing mebicar
03/24/2011	US20110070187 Methods for the Preparation of HCV Polymerase Inhibitors
03/24/2011	US20110070179 Cationic alcohols and uses thereof
03/24/2011	CA2774266A1 Novel tricyclic protein kinase modulators
03/24/2011	CA2774148A1 Tricyclic compounds and pharmaceutical uses thereof
03/24/2011	CA2774018A1 Process for preparing 3-[(4s)-8-bromo-1-methyl-6-(2-pyridinyl)-4h-imidazo[1,2-a][1,4]benzodiazepine-4-yl]propionic acid methyl ester or the benzene sulfonate salt thereof, and compounds useful in that process
03/24/2011	CA2773772A1 2'-fluoro substituted carba-nucleoside analogs for antiviral treatment
03/24/2011	CA2772792A1 Process for preparing azabicyclic compounds
03/24/2011	CA2772689A1 Glycine compound
03/24/2011	CA2772105A1 Fused triazole amines as p2x7 modulators
03/24/2011	CA2771176A1 Macrocyclic inhibitors of jak
03/23/2011	EP2298775A1 Diazabicyclic central nervous system active agents
03/23/2011	EP2298774A1 Halogen compound, polycyclic compound and organic electroluminescent element using the polycyclic compound
03/23/2011	EP2298773A1 6-Cyclomethyl and 6-alkylmethyl substituted pyrazolopyrimidines
03/23/2011	EP2298772A1 Fused heterocyclic compounds
03/23/2011	EP2298771A2 Organic Light-Emitting Device
03/23/2011	EP2298770A1 Heterocyclic compounds as TrkA modulators
03/23/2011	EP2298768A1 5-amino-2,4,7-trioxo-3,4,7,8-tetrahydro-2H-pyrido[2,3-d]pyrimidine derivatives and related compounds for the treatment of cancer
03/23/2011	EP2298759A1 Anabaseine derivatives useful in the treatment of neurodegenerative diseases
03/23/2011	EP2298758A1 Anabaseine derivatives useful in the treatment of neurodegenerative diseases
03/23/2011	EP2298739A1 Organic light emitting device containing polycyclic heteroaryl compounds
03/23/2011	EP2297159A2 Substituted quinazolines
03/23/2011	EP2297158A1 Substituted quinazolines as blood platelet lowering agents
03/23/2011	EP2297157A1 2h- pyrimido ý2, 1-b¨quinaz0lin-2-0ne derivatives and their use as platelet anti-aggregative agents
03/23/2011	EP2297156A1 Substituted quinazolines and their uses for myeoloprolific and thrombotic diseases
03/23/2011	EP2297155A2 Method for producing bicyclic guanidines by use of a cyclic urea
03/23/2011	EP2297154A1 1- (7-(hexahydropyrrolo [3, 4-c]pyrrol-2 (1h) -yl) quin0lin-4-yl) -3- (pyrazin-2-yl) urea derivatives and related compounds as glycogen synthase kinase 3 (gsk-3)
03/23/2011	EP2297153A1 Limk2 inhibitors, compositions comprising them, and methods of their use
03/23/2011	EP2297152A1 Anhydrous crystal form of orvepitant maleate
03/23/2011	EP2297151A1 Inhibitors of protein kinases
03/23/2011	EP2297150A1 Substituted quinazolines as blood platelet lowering agents
03/23/2011	EP2297148A1 Novel derivatives of (bridged piperazinyl)-1-alcanone and use thereof as p75 inhibitors
03/23/2011	EP2297144A1 Imidazopyridine and related analogs as sirtuin modulators
03/23/2011	EP2297140A1 Novel 1,2,4 oxadiazole compounds and methods of use thereof
03/23/2011	EP2297114A2 Heterocyclic compound and use thereof
03/23/2011	EP2297106A1 Phenoxypyridinylamide derivatives and their use in the treatment of pde4 mediated disease states
03/23/2011	EP2297105A1 Substituted amides, method of making, and use as btk inhibitors
03/23/2011	EP2297099A1 3-cyanoalkyl- and 3-hydroxyalkylindoles and use thereof
03/23/2011	EP2205604B1 {[5-(phenyl)-6-phenylpyrrolo[2,1-f][2,1,4]triazin-4-yl]amino}carboxylic acid derivatives and related compounds as prostacyclin (pgi2) ip receptor activators for treating cardiovascular disorders
03/23/2011	EP2118111B1 2-amin0-5, 7-dihydr0-6h- pyrrolo [3, 4-d] pyrimidine derivatives as hsp-90 inhibitors for treating cancer
03/23/2011	EP2081933B1 Pyrazolopyrimidines as pi3k lipid kinase inhibitors
03/23/2011	EP1844049B1 Long wavelength shifted benzotriazole uv-absorbers and their use
03/23/2011	EP1278748B1 Inhibitors of human phosphatidyl-inositol 3-kinase delta
03/23/2011	CN101990718A Organic electroluminescent device
03/23/2011	CN101990540A Lyotropic liquid crystal systems based on bisacenaphthopyrazinoquinoxaline derivatives and methods of making
03/23/2011	CN101987847A Novel heterocyclic NF-kB inhibitors
03/23/2011	CN101357924B Dipeptidase-IV inhibitor compound
03/23/2011	CN101357923B Dipeptidase inhibitor compound
03/23/2011	CN101031620B Use of pyrimido [5, 4-g] pteridines as shading component in color filter colorant compositions
03/22/2011	US7910733 Image-forming material
03/22/2011	US7910601 Heterocyclic aromatic compounds useful as growth hormone secretagogues
03/22/2011	US7910597 platelet lowering agent anagrelide especially 3-and 5-substituted analogues, with reduced potential for cardiovascular side-effects; imidazo[2,1-b]quinazolin-2-one derivatives; by inhibiting megakaryocytopoeisis; antiproliferative agents
03/22/2011	US7910596 Aminotetrahydropyrans as dipeptidyl peptidase-IV inhibitors for the treatment or prevention of diabetes
03/22/2011	US7910594 Antiproliferative agents; gene overexpression
03/22/2011	US7910593 Water-soluble prodrugs
03/22/2011	US7910586 Drug screening; administering secretase inhibitor; Alzheimer's disease
03/22/2011	US7910578 8,10-diaza-bicyclo[4.3.1]decane derivatives and their medical use
03/22/2011	US7910561 Inhibitors of Akt activity
03/22/2011	CA2497440C Pyrazolopyrimidines as cyclin-dependent kinase inhibitors
03/22/2011	CA2480880C Inhibitors of akt activity
03/22/2011	CA2471538C Pyrrolopyrimidines
03/17/2011	WO2011032050A2 Gyrase inhibitors
03/17/2011	WO2011031818A2 Histamine h3 inverse agonists and antagonists and methods of use thereof
03/17/2011	WO2011031816A2 Histamine h3 inverse agonists and antagonists and methods of use thereof
03/17/2011	WO2011031745A1 Antibacterial fluoroquinolone analogs
03/17/2011	WO2011031744A1 Antibacterial fluoroquinolone analogs
03/17/2011	WO2011031554A2 Heterocyclic compounds as janus kinase inhibitors
03/17/2011	WO2011031187A1 Antimicrobial agents based on hemin derivatives
03/17/2011	WO2011031073A2 Novel tetra-aza macrocyclic compound, method for preparing same, and use thereof
03/17/2011	WO2011029915A1 Ether derivatives of bicyclic heteroaryls
03/17/2011	WO2011029804A1 Inhibitors of jak
03/17/2011	WO2011029775A1 [1,2,4]TRIAZOLO [1,5-c]PYRIMIDINE DERIVATIVES AS Hsup90 MODULATORS
03/17/2011	WO2011029279A1 Fused heteroaryl compounds, preparation method and use thereof
03/17/2011	WO2011008312A3 Indole and indoline derivatives and methods of use thereof
03/17/2011	US20110065928 Process for Preparing Azabicyclic Compounds
03/17/2011	US20110065918 New phenylalanine derivatives
03/17/2011	US20110065916 Method of making imidazoazepinone compounds
03/17/2011	US20110065915 Catalysts for metathesis reactions including enantioselective olefin metathesis, and related methods
03/17/2011	US20110065896 Polyether polyol dendron conjugates with effector molecules for biological targeting
03/17/2011	US20110065730 6-cyclylmethyl-and 6-alkylmethyl-substituted pyrazolepyrimidines
03/17/2011	US20110065729 Methods and compositions for ameliorating the undesirable effects of chemotherapy
03/17/2011	US20110065728 Lipoprotein lipase-activating compositions comprising benzene derivatives
03/17/2011	US20110065714 Substituted quinazolines
03/17/2011	US20110065712 Tricyclic compounds and pharmaceutical uses thereof
03/17/2011	US20110065711 Substituted triazolo-pyridazine derivatives
03/17/2011	US20110065709 Aurora kinase modulators and method of use
03/17/2011	US20110065708 Heterocyclic oxime compounds

1 ... 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 ... 573